Hatice Yesim Karasulu | Cellular Microenvironment Interactions | Excellence in Research

Posted on by sciencefather

Prof. Dr. Hatice Yesim Karasulu | Cellular Microenvironment Interactions | Excellence in Research

Prof. Dr. Hatice Yesim Karasulu , Ege University , Turkey

Prof. Dr. H. Yesim Karasulu is a distinguished academician in the field of pharmaceutical technology, currently serving as a Professor in the Department of Pharmaceutical Technology at Ege University, Faculty of Pharmacy, Turkey. She completed her Ph.D. at Ege University and advanced to Associate Professor in 2006 and Professor in 2011. Her work as a consultant at Ege University’s ARGEFAR since 2011 and her contributions to the Turkish Ministry of Health’s Pharmaceutical and Medical Devices Agency (2006–2024) underscore her significant impact on both academia and industry. She has collaborated on international research and development projects, and her achievements include patents and international grant-funded projects. Prof. Karasulu has published over 50 scientific papers and delivered numerous oral and poster presentations. Her expertise spans pharmaceutical formulations, drug delivery systems, and biopharmaceutics, positioning her as a leader in her field.

Publication Profile:

Google Scholar

Strengths for the Award:

Prof. Dr. H. Yeşim Karasulu is a highly accomplished and influential researcher in the field of pharmaceutical technology. With more than 50 publications, including articles in top journals and book chapters, she has demonstrated a deep commitment to advancing pharmaceutical research, particularly in the area of drug delivery systems. Her pioneering work on colloidal drug delivery systems such as liposomes, nano/microparticles, and SEDDS has had significant implications for drug development. Her collaboration with both academic institutions and the pharmaceutical industry, leading to patents and commercial products under pharmaceutical license, highlights the practical impact of her work. Additionally, her extensive involvement in research projects funded at national and international levels, as well as her leadership roles, showcases her ability to drive innovation and contribute to the scientific community.

Areas for Improvement:

While Prof. Dr. Karasulu has made remarkable contributions, continuing to build collaborative networks with global research institutions and fostering interdisciplinary research could help broaden the impact of her findings. Enhancing visibility in high-impact international conferences or fostering collaborations in underexplored regions might allow her work to reach new audiences, ensuring that her innovations in drug delivery systems are applied more widely across different health sectors.

Education:

Prof. Dr. H. Yesim Karasulu earned her Ph.D. in Pharmaceutical Technology from Ege University, Faculty of Pharmacy, where she also completed her undergraduate studies. Her academic journey includes post-doctoral research at the University of Vienna, Department of Pharmaceutical Technology and Biopharmaceutics, working under Prof. Dr. Franz Gabor. Prof. Karasulu’s comprehensive education laid a strong foundation for her pioneering research in the field of drug delivery systems. Her work has been recognized both nationally and internationally, as evidenced by her academic promotions and various prestigious grants. She has also contributed to the development of new pharmaceutical technologies, and her research has influenced both educational and professional practices in the pharmaceutical industry. Prof. Karasulu’s educational journey is marked by continuous development and contributions to advancing pharmaceutical sciences, which is reflected in her ongoing academic and consulting roles.

Experience:

Prof. Dr. H. Yesim Karasulu has a rich professional background in pharmaceutical sciences. After earning her Ph.D., she quickly advanced in academia, being promoted to Associate Professor in 2006 and Professor in 2011. Alongside her academic career, Prof. Karasulu has served as a consultant at Ege University’s ARGEFAR, contributing to the development of innovative drug delivery systems and pharmaceutical technologies. Her extensive experience in the pharmaceutical sector includes her role as a member of the Pharmaceutical Technology Commission at the Turkish Ministry of Health’s Pharmaceuticals and Medical Devices Agency from 2006 to 2024. Prof. Karasulu has also conducted post-doctoral research in Vienna, enhancing her expertise in drug delivery and biopharmaceutics. Her broad range of experiences has led to successful collaborations with both the academic and industrial sectors, resulting in patent applications and new pharmaceutical products, further highlighting her significant contributions to the field of pharmaceutical technology and drug delivery.

Research Focus:

Prof. Dr. H. Yesim Karasulu’s research focuses on the development, characterization, and evaluation of advanced drug delivery systems, particularly colloidal systems such as liposomes, nanoparticles, microemulsions, and self-emulsifying drug delivery systems (SEDDS). Her work aims to enhance the efficacy, stability, and bioavailability of pharmaceuticals, particularly through non-invasive routes like transdermal, nasal, and vaginal delivery. Prof. Karasulu is particularly interested in the physicochemical properties that govern drug absorption and permeation, conducting numerous studies on skin permeation, mucosal delivery, and targeted drug delivery to various organs. Her research is driven by a strong desire to bridge the gap between basic pharmaceutical technology and real-world clinical applications. She has contributed significantly to the scientific understanding of drug release mechanisms and the potential of microemulsions as novel carriers for active pharmaceutical ingredients. Prof. Karasulu’s work has been supported by numerous grants and has led to the development of several patents and ongoing product innovations in the pharmaceutical industry.

Publications Top Notes:

  1. Transdermal delivery of diclofenac sodium through rat skin from various formulations πŸ“„πŸ’Š
  2. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations πŸŒΏπŸ’‰
  3. Microemulsions as novel drug carriers: the formation, stability, applications and toxicity πŸ”¬βš—οΈ
  4. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies πŸ’§πŸ’Š
  5. Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates πŸ“ŠπŸ’‰
  6. Modeling of theophylline release from different geometrical erodible tablets πŸ§¬πŸ“–
  7. Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans πŸ¦ πŸ’Š
  8. Permeation studies and histological examination of sheep nasal mucosa following administration of different nasal formulations with or without absorption enhancers πŸ‘πŸ‘ƒ
  9. Synthesis, molecular modeling, in vivo study, and anticancer activity of 1,2,4‐triazole containing hydrazide–hydrazones derived from (S)‐naproxen πŸ’‘πŸ”¬
  10. Preparation and evaluation of novel microemulsion-based hydrogels for dermal delivery of benzocaine πŸ’§πŸ§΄

Conclusion:

Prof. Dr. H. Yeşim Karasulu is an exemplary candidate for the Excellence in Research award due to her consistent and impactful contributions to pharmaceutical research. Her work has led to significant advancements in drug delivery systems, evidenced by her substantial publication record, patents, and collaborations. Her achievements place her at the forefront of pharmaceutical technology and innovation, making her well-deserving of this recognition.

 

 

 

 

Hatice Yesim Karasulu | Cell Differentiation Processes | Best Innovation Award

Posted on by sciencefather

Prof. Dr. Hatice Yesim Karasulu | Cell Differentiation Processes | Best Innovation Award

Prof. Dr. Hatice Yesim Karasulu , Ege University, Faculty of Pharmacy, Pharmaceutical Technology , Turkey

Prof. Dr. H. Yeşim Karasulu is a distinguished academic and researcher in pharmaceutical technology, based at Ege University in Turkey. With a career spanning decades, she earned her Ph.D. in Pharmaceutical Technology from Ege University, where she became an Associate Professor in 2006 and a full Professor in 2011. Prof. Karasulu has held numerous positions, including consultant for the Ege University Center for Drug Research & Development (ARGEFAR) and member of the pharmaceutical technology commission at Turkey’s Ministry of Health from 2006 to 2024. She has contributed extensively to drug delivery systems and pharmaceutical formulations, especially focusing on colloidal drug delivery. Over the years, she has published over 50 research papers, authored five book chapters, and is the holder of two patents related to nano-drug delivery systems. Her work has advanced both academic knowledge and pharmaceutical industry practices.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Extensive Research Experience: Prof. Dr. H. Yeşim Karasulu has an exceptional track record with more than 50 publications, multiple patents, and ongoing research projects. Her innovative work in colloidal drug delivery systems, including liposomes, nano/microparticles, nano/microemulsions, and self-emulsifying drug delivery systems (SEDDS), positions her as a leading researcher in the pharmaceutical field.
  2. High Impact and Collaboration: Her research is widely cited with an H-index of 16 (WoS) and 18 (Scopus). She has collaborated with prestigious institutions such as the University of Vienna and the Aristotle University of Thessaloniki, further enhancing the global impact of her work.
  3. Patent and Industry Collaboration: Prof. Karasulu’s research has led to two patents and several patent applications, showcasing the practical and commercial value of her innovations. Additionally, her collaborative efforts with the pharmaceutical industry in developing drug delivery systems highlight her ability to bridge academia and industry, enhancing the potential for real-world applications.
  4. Ongoing Research Projects: Prof. Karasulu is involved in multiple research projects, both academic and industry-sponsored, demonstrating her continuous commitment to advancing pharmaceutical sciences. Her ongoing projects include drug delivery systems targeting specific organs and improving drug bioavailability and stability.
  5. Awards and Recognition: Prof. Karasulu’s achievements are recognized through awards such as the Ege ArGe First Prize and the Ege ArGe Innovation Award, confirming the innovative nature of her research.

Areas for Improvement:

  1. Broader International Visibility: While Prof. Karasulu has a strong track record within her field, expanding her international visibility by increasing collaborations with leading global pharmaceutical companies could further enhance the global reach and impact of her innovations.
  2. Diversity of Published Works: Though Prof. Karasulu has an impressive number of publications, exploring opportunities for publication in high-impact journals outside her primary research focus could enhance her visibility in other areas of pharmaceutical sciences.
  3. Focus on Translational Research: While there is a strong emphasis on preclinical studies and formulation development, further focus on clinical trials and commercialization of her innovations could enhance the practical application of her work, especially with regard to regulatory approval processes for new drug delivery systems.

Education:

Prof. Dr. H. Yeşim Karasulu pursued her academic studies at Ege University in Izmir, Turkey. She completed her Bachelor’s degree in Pharmacy at the Faculty of Pharmacy before obtaining a Ph.D. in Pharmaceutical Technology from the same institution. Her education continued with postdoctoral research at the University of Vienna, focusing on Pharmaceutical Technology and Biopharmaceutics under the guidance of Prof. Dr. Franz Gabor. This international research experience allowed her to expand her expertise in colloidal drug delivery systems, setting the foundation for her career as a researcher. Throughout her education, Prof. Karasulu’s work has concentrated on the development of drug delivery systems, with an emphasis on enhancing the bioavailability and targeting of drugs using innovative methods like liposomes, nano/microparticles, and microemulsions. Her academic background has enabled her to contribute significantly to both research and industry practices in pharmaceutical sciences.

Experience:

Prof. Dr. H. Yeşim Karasulu has a distinguished career in both academia and the pharmaceutical industry. She began her academic career as a faculty member at Ege University, where she progressed from an Assistant Professor to a full Professor in the Department of Pharmaceutical Technology. Additionally, she has been an active consultant at the Ege University Center for Drug Research & Development (ARGEFAR) since 2011. Prof. Karasulu also served as a member of the Pharmaceutical Technology Commission at the Turkish Ministry of Health’s Pharmaceuticals and Medical Devices Agency between 2006 and 2024, helping shape national pharmaceutical policies. Her extensive research has led to breakthroughs in nano-drug delivery systems, contributing to the development of two patents and several industry projects. She has worked on numerous national and international projects focusing on drug formulation, bioavailability enhancement, and targeting systems, particularly for cancer therapy and chronic diseases.

Research Focus:

Prof. Dr. H. Yeşim Karasulu’s research primarily focuses on the development and evaluation of advanced colloidal drug delivery systems. Her work spans liposomes, nano/microparticles, nano/microemulsions, and self-emulsifying drug delivery systems (SEDDS). These innovative systems aim to enhance the bioavailability, stability, and targeted delivery of pharmaceutical compounds. Prof. Karasulu has led several high-impact research projects funded by both national (TUBΔ°TAK) and international bodies, such as the European Union. Her research is dedicated to improving the therapeutic efficacy of drugs, particularly in challenging areas like cancer treatment and chronic diseases. Prof. Karasulu’s work is closely aligned with real-world applications, as evidenced by her ongoing collaboration with the pharmaceutical industry to bring new drug delivery systems to market. Her goal is to create formulations that not only improve patient outcomes but also contribute to the overall advancement of pharmaceutical technology.

Publications Top Notes:

  1. “Degradation and gastrointestinal stability of nitrofurantoin in acidic and alkaline media” πŸ“‰πŸ’Š
  2. “Sustained-release dosage form of nitrofurantoin: Part 1. Preparation of microcapsules and in vitro release kinetics” πŸ’ŠπŸ”¬
  3. “33 factorial design-based optimization of the formulation of nitrofurantoin microcapsules” πŸ”¬πŸ“Š
  4. “In vitro-in vivo correlations of nitrofurantoin matrix tablet formulation” πŸ’Šβš–οΈ
  5. “A New In Vitro/In Vivo Kinetic Correlation Method for Nitrofurantoin Matrix Tablet Formulations” πŸ§ͺπŸ’‘
  6. “Sustained release bioadhesive effervescent ketoconazole microcapsules tabletted for vaginal delivery” πŸ’ŠπŸ’₯
  7. “Different geometric shaped hydrogel theophylline tablets: Statistical approach for estimating drug release” πŸ’ŠπŸ“
  8. “Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates” πŸ’ŠπŸ”’
  9. “Improving of the accuracy of in vitro-in vivo linear correlation using kinetic models for ultra sustained release theophylline tablets” πŸ§ͺπŸ“Š
  10. “Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida Albicans” πŸ’ŠπŸ¦ 
  11. “Preparation of arsenic trioxide-loaded microemulsion and its enhanced cytotoxicity on MCF-7 breast carcinoma cell line” πŸ”¬πŸ§ͺ
  12. “In vitro permeation of diclofenac sodium from novel microemulsion formulations through rabbit skin” πŸ’ŠπŸ‡
  13. “Arsenic trioxide-loaded, microemulsion-enhanced cytotoxicity on MDAH 2774 ovarian carcinoma cell line” πŸ”¬πŸ’‰
  14. “Transdermal delivery of diclofenac sodium through rat skin from various formulations” πŸ’ŠπŸ¦·
  15. “Controlled release of methotrexate from W/O microemulsion and its in vitro anti-tumor activity” πŸ§ͺπŸ’₯

Conclusion:

Prof. Dr. H. Yeşim Karasulu is a highly deserving candidate for the Best Innovation Award. Her groundbreaking research in colloidal drug delivery systems has significantly contributed to advancements in pharmaceutical sciences. With numerous publications, patents, and collaborations, her work not only pushes the boundaries of scientific research but also has a profound impact on drug development. By focusing on broader international collaborations and further developing translational research strategies, Prof. Karasulu’s contributions to the pharmaceutical industry and academic community will continue to grow, solidifying her place as a leader in innovation.